Prosecution Insights
Last updated: April 19, 2026

Nutrarex Biotech Co. Ltd.

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18150984 METHOD FOR INCREASING MELATONIN IN SUBJECT AND REGULATING EXPRESSION OF TPH GENE, DDC GENE, AANAT GENE, AND ASMT GENE BY USING LONGAN FLOWER EXTRACT CAIN, JENNIFER LYNN 1655 Final Rejection Jan 06, 2023

Managing Nutrarex Biotech Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month